Skip to content

Author

M. Scheidt

We have 1 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world efficacy and tolerability of lipid-lowering therapy in children with monogenic familial hypercholesterolemia in primary care

LLM can be safely and effectively administered in primary care for children with monogenic FH and already low-dose statins resulted in substantial LDL-C reduction, demonstrating real world applicability of guideline recommendations for early start of treatment in FH in a primary care setting.

R. Schmieder, J. Krefting, S. Arens et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.